Overview
- The Washington Post reported Thursday that finasteride, a hair‑loss drug President Trump took during his first term, does not appear in his latest Walter Reed medical summary.
- Lab results cited by physicians show a roughly tenfold rise in Trump’s prostate‑specific antigen from about 0.1 last year to about 1.0 in the most recent testing.
- Medical experts say the omission matters because finasteride lowers PSA levels so stopping it can raise PSA without disease, while an unexplained PSA rise can also signal prostate pathology.
- The White House said the report lists all medications deemed clinically relevant and that no material health conditions were omitted while concluding the president remains in excellent physical health.
- Commentators and ethicists have called for clearer disclosure, noting finasteride’s side effects and past White House opacity, and warning the issue could prompt further scrutiny of the president’s fitness and medical transparency.